Journal of Law, Medicine and Ethics 41 (1):163-184 (2013)

Industry control over the production and distribution of pharmaceutical safety and efficacy data has become a serious public health and health care funding concern. Various recent scandals, several involving the use of flawed representations of scientific data in the most influential medical journals, highlight the urgency of enhancing pharmaceutical knowledge governance. This paper analyzes why this is a human rights concern and what difference a human rights analysis can make. The paper first identifies the challenges associated with the current knowledge deficit. It then discusses, based on an analysis of case law, how various human rights associated interests can be invoked to support the claim that states have an obligation to actively contribute to independent knowledge governance, for example through ensuring clinical trials transparency. The paper further discusses a conceptual use of human rights, as a methodology which requires a comprehensive analysis of the different interwoven historical, economic, cultural, and social factors that contribute to the problem. Such an analysis reveals that historically grown drug regulations have, in fact, contributed directly to industry control over pharmaceutical knowledge production. This type of finding should inform needed reforms of drug regulation. The paper ends with a recommendation for a comprehensive global response to the problem of pharmaceutical knowledge governance
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1111/jlme.12012
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 63,247
Through your library

References found in this work BETA

Better Than Well: American Medicine Meets the American Dream.Carl Elliot - 2008 - International Journal of Feminist Approaches to Bioethics 1 (1):185-188.

View all 11 references / Add more references

Citations of this work BETA

Toward a Jurisprudence of Drug Regulation.Matthew Herder - 2014 - Journal of Law, Medicine and Ethics 42 (2):244-262.
Toward a Jurisprudence of Drug Regulation.Matthew Herder - 2014 - Journal of Law, Medicine and Ethics 42 (2):244-262.

Add more citations

Similar books and articles

Are Pharmaceutical Patents Protected by Human Rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.
Human Rights and Human Security.Jurate Morkuniene - 2008 - Proceedings of the Xxii World Congress of Philosophy 11:77-83.
Global Health Justice and Governance.Jennifer Prah Ruger - 2012 - American Journal of Bioethics 12 (12):35-54.


Added to PP index

Total views
19 ( #560,266 of 2,448,510 )

Recent downloads (6 months)
1 ( #449,843 of 2,448,510 )

How can I increase my downloads?


My notes